Donor CMV- and Adenovirus-specific cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor CMV- and Adenovirus-specific cytotoxic T lymphocytes, covering 2014-10-15 to 2014-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus [Phase 1]